News
Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...
Reiner said weight loss jabs could be the answer, but there are serious problems, adding: "GLP-1-based medications are ...
After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.
Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...
Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy. | Novo Nordisk and Hims & Hers have struck a truce after sparring over ...
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
Shane Harding says she used to drink up to two bottles of wine a night before starting medication, which has helped her lose ...
Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...
Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...
Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results